Literature DB >> 22740748

Primary pericardial mesothelioma unique case and literature review.

Muhammad Rizwan Sardar1, Catherine Kuntz, Toralben Patel, Wajeeha Saeed, Eric Gnall, Shotaro Imaizumi, Leah Lande.   

Abstract

A 72-year-old woman, on warfarin therapy and with a remote history of breast cancer and radiation treatment, presented with a 10-day history of nausea, dyspnea, dry cough, and dizziness. An electrocardiogram showed new-onset atrial fibrillation. Computed tomography of the chest revealed multiple pulmonary emboli and a pericardial effusion. Echocardiography showed a pericardial effusion with tamponade characteristics. The patient's condition deteriorated, and a pericardiectomy was performed. Histologic evaluation confirmed primary pericardial mesothelioma. She underwent palliative treatment and died 3 months after discharge from the hospital. We discuss the patient's case and the nature of primary pericardial mesothelioma, a rare oncologic entity.

Entities:  

Keywords:  Cardiac tamponade/etiology; fatal outcome; heart neoplasms/complications/diagnosis/pathology/ultrasonography; mesothelioma/complications/diagnosis/pathology; pericardial effusion/etiology; pericardiectomy; pulmonary embolism/pathology

Mesh:

Substances:

Year:  2012        PMID: 22740748      PMCID: PMC3384041     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  12 in total

1.  Primary pericardial mesothelioma in an asbestos-exposed patient with previous heart surgery.

Authors:  Clara Rizzardi; Elena Barresi; Alessandro Brollo; Paolo Cassetti; Manuela Schneider; Mauro Melato
Journal:  Anticancer Res       Date:  2010-04       Impact factor: 2.480

2.  Lovastatin induces apoptosis in malignant mesothelioma cells.

Authors:  J B Rubins; T Greatens; R A Kratzke; A T Tan; V A Polunovsky; P Bitterman
Journal:  Am J Respir Crit Care Med       Date:  1998-05       Impact factor: 21.405

3.  Magnetic resonance imaging findings in a patient with pericardial mesothelioma.

Authors:  H D Gössinger; P Siostrzonek; M Zangeneh; A Neuhold; C Herold; R Schmoliner; A Laczkovics; D Tscholakoff; H Mösslacher
Journal:  Am Heart J       Date:  1988-06       Impact factor: 4.749

4.  Primary pericardial mesothelioma: diagnostic and therapeutic challenges in management.

Authors:  J Hollins; A Lowman; M E Assey
Journal:  South Med J       Date:  1988-04       Impact factor: 0.954

Review 5.  Primary malignant pericardial mesothelioma: a case report and review.

Authors:  T K Kaul; B L Fields; D R Kahn
Journal:  J Cardiovasc Surg (Torino)       Date:  1994-06       Impact factor: 1.888

6.  Statins revert doxorubicin resistance via nitric oxide in malignant mesothelioma.

Authors:  Chiara Riganti; Sara Orecchia; Gianpiero Pescarmona; Pier Giacomo Betta; Dario Ghigo; Amalia Bosia
Journal:  Int J Cancer       Date:  2006-07-01       Impact factor: 7.396

7.  [Pulmonary embolism in malignancy of the lung: a retrospective clinical evaluation and pathomorphologic personal material].

Authors:  B Vertun-Baranowska; A Fijałkowska; W Tomkowski; S Filipecki; D Szymańska
Journal:  Pneumonol Alergol Pol       Date:  1996

Review 8.  New approaches for mesothelioma: biologics, vaccines, gene therapy, and other novel agents.

Authors:  Anna K Nowak; Richard A Lake; Hedy Lee Kindler; Bruce W S Robinson
Journal:  Semin Oncol       Date:  2002-02       Impact factor: 4.929

9.  Triplet chemotherapy for malignant pericardial mesothelioma: a case report.

Authors:  Riichiroh Maruyama; Maki Sakai; Tomomi Nakamura; Ryuichi Suemitsu; Tatsuro Okamoto; Hiroshi Wataya; Kenichi Nishiyama; Toshiaki Kamei; Yukito Ichinose
Journal:  Jpn J Clin Oncol       Date:  2006-03-13       Impact factor: 3.019

10.  [Primary malignant pericardial mesothelioma].

Authors:  T Fazekas; L Tiszlavicz; I Ungi
Journal:  Orv Hetil       Date:  1991-12-01       Impact factor: 0.540

View more
  8 in total

1.  A rare cause of heart failure with preserved ejection fraction: primary pericardial mesothelioma masquerading as pericardial constriction.

Authors:  Russell Fernandes; Shravan Nosib; Dorothy Thomson; Nick Baniak
Journal:  BMJ Case Rep       Date:  2014-03-20

2.  Malignant pericardial mesothelioma : A systematic review of current practice.

Authors:  S Cao; S Jin; J Cao; J Shen; H Zhang; Q Meng; B Pan; Y Yu
Journal:  Herz       Date:  2017-01-27       Impact factor: 1.443

3.  Primary malignant pericardial mesothelioma-a rare cause of superior vena cava thrombosis and constrictive pericarditis.

Authors:  Wenhui Gong; Xiaofeng Ye; Kaihu Shi; Qiang Zhao
Journal:  J Thorac Dis       Date:  2014-12       Impact factor: 2.895

4.  Malignant mesothelioma of the pericardium: a report of two different presentations.

Authors:  Pattarapong Makarawate; Narumol Chaosuwannakit; Jarin Chindaprasirt; Piti Ungarreevittaya; Surachat Chaiwiriyakul; Kosin Wirasorn; Chusak Kuptarnond; Kittisak Sawanyawisuth
Journal:  Case Rep Oncol Med       Date:  2013-08-21

5.  Sarcomatoid Type Primary Pericardial Mesothelioma with a Long-term Survival after the Onset of Cardiac Tamponade.

Authors:  Chika Saisho; Hidenobu Ishii; Nobutaka Edakuni; Yohei Imamura; Takaaki Tokito; Takashi Kinoshita; Koichi Azuma; Kazuhiko Yamada; Tomoaki Hoshino
Journal:  Intern Med       Date:  2016-11-01       Impact factor: 1.271

6.  A case report of malignant primary pericardial mesothelioma with atypical imaging appearance: multimodality imaging with histopathological correlation.

Authors:  Audra Banišauskaitė; Antanas Jankauskas; Valdas Šarauskas; Monika Aržanauskaitė
Journal:  Eur Heart J Case Rep       Date:  2020-02-27

7.  A Case Report of Primary Pericardial Malignant Mesothelioma Treated with Pemetrexed and Cisplatin.

Authors:  Jung Sun Kim; Sang Yup Lim; Jinwook Hwang; Eun Joo Kang; Yoon Ji Choi
Journal:  J Korean Med Sci       Date:  2017-11       Impact factor: 2.153

8.  F-18 FDG PET/CT images of a rare primer cardiac tumour: Primary Pericardial Mesothelioma.

Authors:  İlknur Ak Sivrikoz; Hasan Önner; Emine Kasapoğlu Dündar; Yüksel Çavuşoğlu; Sadettin Dernek
Journal:  Anatol J Cardiol       Date:  2016-08       Impact factor: 1.596

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.